PlainRecalls
FDA Drug Moderate Class II Terminated

Acarbose Tablets, 25 mg, 100-count bottle, Rx only, Manufactured by: Arrow Pharm (Malta) Ltd., Birzebbugia BBG3000, Malta; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054; NDC 16252-523-01.

Reported: October 4, 2017 Initiated: September 5, 2017 #D-1178-2017

Product Description

Acarbose Tablets, 25 mg, 100-count bottle, Rx only, Manufactured by: Arrow Pharm (Malta) Ltd., Birzebbugia BBG3000, Malta; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054; NDC 16252-523-01.

Reason for Recall

Labeling: Incorrect or Missing Lot and/or Exp Date: An incorrect expiration date of July 2018 is printed on the product labeling rather than the correct expiration date of July 2017.

Details

Recalling Firm
Teva Pharmaceuticals USA
Units Affected
3,275 bottles
Distribution
Nationwide in the USA
Location
North Wales, PA

Frequently Asked Questions

What product was recalled?
Acarbose Tablets, 25 mg, 100-count bottle, Rx only, Manufactured by: Arrow Pharm (Malta) Ltd., Birzebbugia BBG3000, Malta; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054; NDC 16252-523-01.. Recalled by Teva Pharmaceuticals USA. Units affected: 3,275 bottles.
Why was this product recalled?
Labeling: Incorrect or Missing Lot and/or Exp Date: An incorrect expiration date of July 2018 is printed on the product labeling rather than the correct expiration date of July 2017.
Which agency issued this recall?
This recall was issued by the FDA Drug on October 4, 2017. Severity: Moderate. Recall number: D-1178-2017.